Navigation Links
Xenome Receives a Syndicated US$10 Million Equity Investment from Queensland BioCapital Fund, Amylin Pharmaceuticals and Innovis Investment Partners
Date:11/27/2007

BRISBANE, Australia, Nov. 27 /PRNewswire/ -- Xenome Ltd, a specialist biopharmaceutical company developing novel peptide drugs, announced today that it has successfully raised US$10M of equity finance. The syndicated funding round includes continuing support from Xenome's major investor, Queensland BioCapital Funds (QBF), for $2.7M, significant equity funding of $5m from Amylin Pharmaceuticals Inc, a top tier USA biotechnology company headquartered in San Diego, California, and $2.3M from Innovis Investment Partners (Innovis).

The combined investment will enable Xenome to continue the execution of its operational plan which includes:
- Implementation of a Joint Xenome-Amylin Research Collaboration

involving drug discovery of new compounds from Xenome's unique

peptide library using Amylin's assay technologies in the fields of

metabolic and musculoskeletal diseases;

- Expansion of the Phase 2 clinical development of Xenome's most

advanced and promising drug candidate, Xen2174, for the treatment of

acute and chronic intractable pain and;

- Furthering the development of Xenome's current drug candidate

pipeline.

"The opportunity to make two major announcements on the same day does not come around very often, so it is satisfying to be able to announce this new syndicated investment by QBF, Amylin and Innovis together with the execution of the separate Joint Xenome-Amylin Research Collaboration. The Company recognizes QBF's sustained support and belief in Xenome at a time when biotech funding comes at a premium. At the same time we welcome new substantial shareholders Amylin and Innovis Ltd. to the Company's share register." said Xenome CEO, Lewis Lee.

"The equity investment integrated with the extensive Xenome-Amylin Joint Research Collaboration provides a tremendous validation of the Company's peptide drug discovery platform and will facilitate Xenome's ability to rapidly ge
'/>"/>

SOURCE Xenome Ltd
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
3. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
4. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
5. IsoTis Receives FDA Clearance for Accell Family of Products
6. Actavis Receives Approval of Fentanyl Transdermal System in the U.S.
7. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
8. IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma
9. XTL Receives Staff Letter From NASDAQ
10. XTL Receives Staff Letter From NASDAQ; XTL may Transfer its ADR Listing to the NASDAQ Capital Market
11. Hemo-Stream(TM) Chronic Dialysis Catheter Receives FDA Clearance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... 28, 2014  InterMune, Inc. (NASDAQ: ITMN ... quarter 2014 financial results at the close of the ... call and webcast will be hosted by InterMune at ... Interested investors and others may participate in the conference ... conference ID#21728775. A replay of the webcast and teleconference will ...
(Date:7/28/2014)... 2014 The National Model Aviation Museum, ... is pleased to announce that it has been granted ... the United States Air Force. , The certification is ... concluded this spring with an on-site inspection by Sarah ... , The National Museum of the United States ...
(Date:7/25/2014)... THOUSAND OAKS, Calif. , July 25, 2014 /PRNewswire/ ... its Board of Directors today declared a $0.61 per ... dividend will be paid on Sept. 5, 2014, to ... business on Aug. 14, 2014.  About ... biology for patients suffering from serious illnesses by discovering, ...
(Date:7/25/2014)... , July 25, 2014 Research ... "Global Metabolomics Market 2014-2018" report to ... Metabolomics or Metabonomics is the ... has become a new experimental technique that is ... environmental sciences. Metabolites are small molecules that are ...
Breaking Biology Technology:InterMune to Release Second Quarter Financial Results on August 6 2AMA’s National Model Aviation Museum Granted Full Civilian Museum Certification by the National Museum of the United States Air Force 2Amgen Announces 2014 Third Quarter Dividend 2Amgen Announces 2014 Third Quarter Dividend 3Global Metabolomics Market 2014-2018: Key Vendors are Agilent, Bio-Rad, Bruker, Human Metabolome and Metabolon 2
... SAN DIEGO, Jan. 4, 2012  Halozyme Therapeutics, Inc. (NASDAQ: ... Morgan Healthcare Conference in San Francisco on Wednesday, January ... ET . Greg I. Frost, Ph.D., president and ... corporate overview. (Logo: http://photos.prnewswire.com/prnh/20100302/LA63139LOGO ) ...
... a leader in personal genetics, has released its second ... most interesting and significant genetic findings in 2011, as ... of genetics in personal health and human development. ... "The genetics revolution is well underway and 2011 had ...
... of thought leaders in Alzheimer,s disease says the science ... widespread use of biomarkers in Alzheimer disease (AD) clinical ... for this incurable disorder. Recommendations by the Alzheimer,s Disease ... for Aging Research in cooperation with the Food and ...
Cached Biology Technology:23andMe Presents Top Ten Most Interesting Genetic Findings of 2011 223andMe Presents Top Ten Most Interesting Genetic Findings of 2011 323andMe Presents Top Ten Most Interesting Genetic Findings of 2011 423andMe Presents Top Ten Most Interesting Genetic Findings of 2011 523andMe Presents Top Ten Most Interesting Genetic Findings of 2011 623andMe Presents Top Ten Most Interesting Genetic Findings of 2011 7Use Biomarkers in Alzheimer's Disease Clinical Trials, Says Expert Group 2Use Biomarkers in Alzheimer's Disease Clinical Trials, Says Expert Group 3
(Date:7/25/2014)... raging this summer and some of the smoke from those ... image collected by the Moderate Resolution Imaging Spectroradiometer (MODIS) aboard ... smoke has descended over the Great Lakes region of the ... image from July 23, 2014 (first image feature highlighted below) ... off southeastward. In the image, it is over Manitoba ...
(Date:7/25/2014)... from 25 countries and 35 states will attend ... Genetics Society of America (GSA) next week at ... will feature close to 500 presentations (including 70 ... gene expression and regulation, functional genomics, chemical biology ... a variety of diseases. , Of special ...
(Date:7/25/2014)... at the University of Adelaide has opened the way for ... powdery mildew. , In Australia, annual barley production is second ... mildew is one of the most important diseases of barley. ... discovered the composition of special growths on the cell walls ... into the leaf. , The research, by the ARC Centre ...
Breaking Biology News(10 mins):Yeast meeting to showcase latest breakthroughs in genetics and molecular biology 2New hope for powdery mildew resistant barley 2
... snakes, tumour cells shed their skin. Cancer is not ... accumulates changes to evade natural defences adapting to new ... neighbouring organs, eventually causing metastasis. Until now little ... processes in a tumour. There is a particularly intriguing ...
... Yale University researchers have identified a key genetic gear ... that could have broad implications for global agriculture. The ... Molecular Cell. "Farmers are limited by the ... controls basic functions such as photosynthesis and flowering, we might ...
... detective work by an international group of researchers may have ... tree-killing fungus that has hit six of the world,s seven ... 1) in the peer-reviewed journal Phytopathology , California emerged ... is the cause of cypress canker disease. It was ...
Cached Biology News:Why cancer cells change their appearance? 2Tree-killing pathogen traced back to California 2Tree-killing pathogen traced back to California 3Tree-killing pathogen traced back to California 4Tree-killing pathogen traced back to California 5
The Varian 4000 GC/MS system offers three easily switchable ionization configurations: internal ionization (II), external ionization (EI) or hybrid chemical ionization (CI)...
GeneRacer is an advanced RACE (rapid amplification of cDNA ends) technique that improves the efficiency of amplifying full-length 5' and 3' cDNA ends. With the GeneRacer Kit you can:...
One-step, microplate or cuvet, colorimetric, detection range 0.04% to 4%. Procedure: 30 min....
... to Presenilin 2 Alzheimer's disease (AD) ... disease carry mutations in the presenilin proteins ... (APP). These disease-linked mutations result in increased ... (main component of amyloid deposits found in ...
Biology Products: